Akin Advises Pharmakon Advisors in Its $250 Million Debt Financing for Geron Corporation
November 20, 2024
November 20, 2024
WASHINGTON, Nov. 20 -- Akin Gump, a law firm, issued the following news release:
(New York) - Akin advised Pharmakon Advisors, LP and its investment funds in providing Geron Corporation, a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, with $250 million of committed senior secured debt financing, alongside a $125 million synthetic royalty with Royalty Pharma, to support the commercial launch of RYTELO(TM) in the U.S.
. . .
(New York) - Akin advised Pharmakon Advisors, LP and its investment funds in providing Geron Corporation, a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, with $250 million of committed senior secured debt financing, alongside a $125 million synthetic royalty with Royalty Pharma, to support the commercial launch of RYTELO(TM) in the U.S.
. . .